Annual Accounts Payable
$2.33 M
+$981.40 K+72.75%
December 31, 2023
Summary
- As of February 7, 2025, INVO annual accounts payable is $2.33 million, with the most recent change of +$981.40 thousand (+72.75%) on December 31, 2023.
- During the last 3 years, INVO annual accounts payable has risen by +$2.00 million (+608.54%).
Performance
INVO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 30, 2024
Summary
- INVO quarterly accounts payable is not available.
Performance
INVO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INVO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +72.8% | - |
3 y3 years | +608.5% | - |
5 y5 years | +307.6% | - |
INVO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -81.0% | ||
5 y | 5-year | at high | -85.9% | ||
alltime | all time | at high | -100.0% |
INVO Bioscience Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $2.33 M(+72.8%) | $2.33 M(+26.2%) |
Mar 2023 | - | $1.85 M(+36.9%) |
Dec 2022 | $1.35 M(+204.2%) | $1.35 M(+204.2%) |
Dec 2021 | $443.40 K(+34.8%) | $443.40 K(-14.0%) |
Sep 2021 | - | $515.60 K(+68.3%) |
Jun 2021 | - | $306.30 K(-40.2%) |
Mar 2021 | - | $512.00 K(+55.7%) |
Dec 2020 | $328.90 K(-11.5%) | $328.90 K(-27.9%) |
Sep 2020 | - | $456.00 K(+47.3%) |
Jun 2020 | - | $309.50 K(+5.0%) |
Mar 2020 | - | $294.70 K(-20.7%) |
Dec 2019 | $371.50 K(-35.0%) | $371.50 K(-18.8%) |
Sep 2019 | - | $457.40 K(-20.0%) |
Dec 2018 | $571.80 K | $571.80 K(-6.6%) |
Sep 2011 | - | $611.90 K(-1.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $623.50 K(+1.2%) |
Mar 2011 | - | $616.40 K(-1.9%) |
Dec 2010 | $628.20 K(-8.1%) | $628.20 K(-9.6%) |
Sep 2010 | - | $695.00 K(+6.7%) |
Jun 2010 | - | $651.10 K(-3.8%) |
Mar 2010 | - | $676.50 K(-1.1%) |
Dec 2009 | $683.80 K(+201.4%) | $683.80 K(+5.2%) |
Sep 2009 | - | $650.20 K(-16.5%) |
Jun 2009 | - | $778.80 K(+39.9%) |
Mar 2009 | - | $556.80 K(+145.4%) |
Dec 2008 | $226.90 K(>+9900.0%) | $226.90 K(+3337.9%) |
Sep 2008 | - | $6600.00(+43.5%) |
Jun 2008 | - | $4600.00(+228.6%) |
Mar 2008 | - | $1400.00(+16.7%) |
Dec 2007 | $1200.00(>+9900.0%) | $1200.00 |
Dec 2006 | $0.00 | - |
FAQ
- What is INVO Bioscience annual accounts payable?
- What is the all time high annual accounts payable for INVO Bioscience?
- What is INVO Bioscience annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for INVO Bioscience?
What is INVO Bioscience annual accounts payable?
The current annual accounts payable of INVO is $2.33 M
What is the all time high annual accounts payable for INVO Bioscience?
INVO Bioscience all-time high annual accounts payable is $2.33 M
What is INVO Bioscience annual accounts payable year-on-year change?
Over the past year, INVO annual accounts payable has changed by +$981.40 K (+72.75%)
What is the all time high quarterly accounts payable for INVO Bioscience?
INVO Bioscience all-time high quarterly accounts payable is $2.33 M